Long-term safety of stimulant medications used to treat children with ADHD

被引:11
|
作者
Lerner, Marc [1 ]
Wigal, Tim [2 ]
机构
[1] Univ Calif Irvine, Med Ctr, Dept Pediat, Orange, CA 92868 USA
[2] Univ Calif Irvine, Child Dev Ctr, Irvine, CA USA
关键词
D O I
10.3928/02793695-20080801-06
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Attention-deficit/hyperactivity disorder (ADHD) is a common mental health condition that affects children, adolescents, and adults. Because it is a chronic and typically requires effective treatment for several years or more, information on the benefits and risks of long-term pharmacotherapy for ADHD is vital to clinicians. This article reviews the emerging literature on the safety of long-term stimulant medications in ADHD-the most commonly prescribed medications for this condition. Common side effects, including cardiovascular effects, growth effects, and tics, are discussed, as well as treatment of children younger than age 6 and evidence of carcinogenic and reproductive effects.
引用
收藏
页码:38 / 48
页数:11
相关论文
共 50 条
  • [31] The ADHD Camp: Long-term effects of an intensive behavioral intervention for children with ADHD
    Schmidt, Soeren
    Ender, Stephanie
    Schultheiss, Jan
    Gerber-von Mueller, Gabriele
    Gerber, Wolf-Dieter
    Steinmann, Elisabeth
    Petermann, Ulrike
    Petermann, Franz
    KINDHEIT UND ENTWICKLUNG, 2012, 21 (02): : 90 - 102
  • [32] Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitis
    Langley, Richard G. B.
    Eichenfield, Lawrence F.
    Lucky, Anne W.
    Boguniewicz, Mark
    Barbier, Nathalie
    Cherill, Robert
    PEDIATRIC DERMATOLOGY, 2008, 25 (03) : 301 - 307
  • [33] Premarket Safety and Efficacy Studies for ADHD Medications in Children
    Bourgeois, Florence T.
    Kim, Jeong Min
    Mandl, Kenneth D.
    PLOS ONE, 2014, 9 (07):
  • [34] Metabolic, toxicological, and safety considerations for drugs used to treat ADHD
    Duong, Sophie
    Chung, Kara
    Wigal, Sharon B.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (05) : 543 - 552
  • [35] Long-Term Effects of Stimulant Treatment for ADHD: What Can We Tell Our Patients?
    Craig S.G.
    Davies G.
    Schibuk L.
    Weiss M.D.
    Hechtman L.
    Current Developmental Disorders Reports, 2015, 2 (1) : 1 - 9
  • [36] Patterns of long-term ADHD medication use in Australian children
    Efron, Daryl
    Mulraney, Melissa
    Sciberras, Emma
    Hiscock, Harriet
    Hearps, Stephen
    Coghill, David
    ARCHIVES OF DISEASE IN CHILDHOOD, 2020, 105 (06) : 593 - 597
  • [37] Long-term effects of Atomoxetine on growth in children and adolescents with ADHD
    Spencer, TJ
    Michelson, D
    Ruff, D
    Moore, RJ
    Feldman, PD
    EUROPEAN PSYCHIATRY, 2004, 19 : 239S - 240S
  • [38] A safety profile of medications used to treat Waldenstrom's macroglobulinemia
    Garcia-Sanz, Ramon
    Jimenez, Cristina
    Gonzalez De La Calle, Veronica
    Eugenia Sarasquete, Maria
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (06) : 609 - 621
  • [39] Enhancing spatial memory and pattern separation: Long-term effects of stimulant treatment in individuals with ADHD
    Lobato-Camacho, Francisco Jose
    Lopez, Juan Carlos
    Vargas, Juan Pedro
    BEHAVIOURAL BRAIN RESEARCH, 2024, 475
  • [40] Long-term effects of stimulant treatment on ADHD symptoms, social-emotional functioning, and cognition
    Schweren, Lizanne
    Hoekstra, Pieter
    van Lieshout, Marloes
    Oosterlaan, Jaap
    Lambregts-Rommelse, Nanda
    Buitelaar, Jan
    Franke, Barbara
    Hartman, Catharina
    PSYCHOLOGICAL MEDICINE, 2019, 49 (02) : 217 - 223